![](en_US" property="og:locale">
<meta content="Vesalius" property="og:site_name">
<meta content="website" property="og:type">
<meta content="https://vesaliustx.com/" property="og:url">
<meta content="Home" property="og:title">
<meta content="At Vesalius Therapeutics, we believe it is time to re-think and redefine how we treat common illnesses. Founded by Flagship Pioneering , we are building a…" property="og:description">
<meta content="https://s3.us-east-1.amazonaws.com/vesalius-craftcms-assets/uploads/_1200x630_crop_center-center_82_none/Logo-Vesalius-Therapeutics@2x.png?mtime=1646097278){kind=logo}
Vesalius Therapeutics
Pioneering breakthrough treatments for common diseases
Cambridge, United States · Founded 2022 · $75.0M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 11–50
- Founded
- 2022
- Business Model
- B2B
- Website
- vesaliustx.com
- Total Funding
- $75.0M
- Last Round
- $75.0M Series CMar 2022
- Rounds
- 1
About
Founded in 2020 and headquartered in Cambridge, Massachusetts, Vesalius Therapeutics discovers and develops drugs by targeting biological circuits within cells to treat diseases underlying common illnesses such as Parkinson's disease. The company is backed by Flagship Pioneering and has a strategic alliance with GSK to develop novel Parkinson's disease treatments.
Summary
Vesalius Therapeutics is a company based in Cambridge, United States, founded in 2022. It has raised $75.0M in total across 1 round, most recently a $75.0M Series C round in Mar 2022. Investors include Flagship Pioneering, ARCH Venture Partners and Monograph Capital.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2022
